vs

Side-by-side financial comparison of POTLATCHDELTIC CORP (PCH) and Privia Health Group, Inc. (PRVA). Click either name above to swap in a different company.

Privia Health Group, Inc. is the larger business by last-quarter revenue ($603.8M vs $314.2M, roughly 1.9× POTLATCHDELTIC CORP). POTLATCHDELTIC CORP runs the higher net margin — 8.2% vs 0.6%, a 7.6% gap on every dollar of revenue. On growth, Privia Health Group, Inc. posted the faster year-over-year revenue change (25.8% vs 23.1%). Over the past eight quarters, Privia Health Group, Inc.'s revenue compounded faster (19.6% CAGR vs 11.1%).

PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

PCH vs PRVA — Head-to-Head

Bigger by revenue
PRVA
PRVA
1.9× larger
PRVA
$603.8M
$314.2M
PCH
Growing faster (revenue YoY)
PRVA
PRVA
+2.6% gap
PRVA
25.8%
23.1%
PCH
Higher net margin
PCH
PCH
7.6% more per $
PCH
8.2%
0.6%
PRVA
Faster 2-yr revenue CAGR
PRVA
PRVA
Annualised
PRVA
19.6%
11.1%
PCH

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
PCH
PCH
PRVA
PRVA
Revenue
$314.2M
$603.8M
Net Profit
$25.9M
$3.7M
Gross Margin
18.2%
20.8%
Operating Margin
11.2%
1.2%
Net Margin
8.2%
0.6%
Revenue YoY
23.1%
25.8%
Net Profit YoY
682.5%
-27.4%
EPS (diluted)
$0.33
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCH
PCH
PRVA
PRVA
Q1 26
$603.8M
Q4 25
$541.2M
Q3 25
$314.2M
$580.4M
Q2 25
$275.0M
$521.2M
Q1 25
$268.3M
$480.1M
Q4 24
$258.1M
$460.9M
Q3 24
$255.1M
$437.9M
Q2 24
$320.7M
$422.3M
Net Profit
PCH
PCH
PRVA
PRVA
Q1 26
$3.7M
Q4 25
$9.2M
Q3 25
$25.9M
$6.9M
Q2 25
$7.4M
$2.7M
Q1 25
$25.8M
$4.2M
Q4 24
$5.2M
$4.4M
Q3 24
$3.3M
$3.5M
Q2 24
$13.7M
$3.5M
Gross Margin
PCH
PCH
PRVA
PRVA
Q1 26
20.8%
Q4 25
Q3 25
18.2%
Q2 25
13.0%
Q1 25
17.8%
Q4 24
13.4%
Q3 24
10.8%
Q2 24
11.9%
Operating Margin
PCH
PCH
PRVA
PRVA
Q1 26
1.2%
Q4 25
2.1%
Q3 25
11.2%
2.5%
Q2 25
5.0%
0.6%
Q1 25
10.3%
1.1%
Q4 24
5.2%
1.1%
Q3 24
2.8%
1.3%
Q2 24
5.4%
1.2%
Net Margin
PCH
PCH
PRVA
PRVA
Q1 26
0.6%
Q4 25
1.7%
Q3 25
8.2%
1.2%
Q2 25
2.7%
0.5%
Q1 25
9.6%
0.9%
Q4 24
2.0%
1.0%
Q3 24
1.3%
0.8%
Q2 24
4.3%
0.8%
EPS (diluted)
PCH
PCH
PRVA
PRVA
Q1 26
$0.02
Q4 25
$0.08
Q3 25
$0.33
$0.05
Q2 25
$0.09
$0.02
Q1 25
$0.33
$0.03
Q4 24
$0.07
$0.03
Q3 24
$0.04
$0.03
Q2 24
$0.17
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCH
PCH
PRVA
PRVA
Cash + ST InvestmentsLiquidity on hand
$88.8M
$419.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$805.9M
Total Assets
$3.2B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCH
PCH
PRVA
PRVA
Q1 26
$419.5M
Q4 25
$479.7M
Q3 25
$88.8M
$441.4M
Q2 25
$95.3M
$390.1M
Q1 25
$147.5M
$469.3M
Q4 24
$151.6M
$491.1M
Q3 24
$161.1M
$422.0M
Q2 24
$199.7M
$387.4M
Total Debt
PCH
PCH
PRVA
PRVA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0B
Q3 24
Q2 24
Stockholders' Equity
PCH
PCH
PRVA
PRVA
Q1 26
$805.9M
Q4 25
$737.2M
Q3 25
$1.9B
$709.1M
Q2 25
$1.9B
$682.9M
Q1 25
$2.0B
$659.4M
Q4 24
$2.0B
$635.2M
Q3 24
$2.1B
$614.9M
Q2 24
$2.1B
$595.4M
Total Assets
PCH
PCH
PRVA
PRVA
Q1 26
$1.4B
Q4 25
$1.4B
Q3 25
$3.2B
$1.4B
Q2 25
$3.2B
$1.3B
Q1 25
$3.3B
$1.2B
Q4 24
$3.3B
$1.1B
Q3 24
$3.3B
$1.1B
Q2 24
$3.4B
$1.1B
Debt / Equity
PCH
PCH
PRVA
PRVA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.51×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCH
PCH
PRVA
PRVA
Operating Cash FlowLast quarter
$65.7M
$-49.5M
Free Cash FlowOCF − Capex
$50.1M
FCF MarginFCF / Revenue
15.9%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
2.54×
-13.33×
TTM Free Cash FlowTrailing 4 quarters
$132.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCH
PCH
PRVA
PRVA
Q1 26
$-49.5M
Q4 25
$127.5M
Q3 25
$65.7M
$52.0M
Q2 25
$41.0M
$8.0M
Q1 25
$49.1M
$-24.1M
Q4 24
$45.4M
$74.8M
Q3 24
$26.5M
$33.2M
Q2 24
$100.6M
$34.5M
Free Cash Flow
PCH
PCH
PRVA
PRVA
Q1 26
Q4 25
Q3 25
$50.1M
Q2 25
$30.6M
Q1 25
$26.3M
Q4 24
$25.4M
Q3 24
$-8.2M
Q2 24
$72.4M
FCF Margin
PCH
PCH
PRVA
PRVA
Q1 26
Q4 25
Q3 25
15.9%
Q2 25
11.1%
Q1 25
9.8%
Q4 24
9.9%
Q3 24
-3.2%
Q2 24
22.6%
Capex Intensity
PCH
PCH
PRVA
PRVA
Q1 26
Q4 25
Q3 25
4.9%
Q2 25
3.8%
Q1 25
8.5%
Q4 24
7.7%
Q3 24
13.6%
Q2 24
8.8%
Cash Conversion
PCH
PCH
PRVA
PRVA
Q1 26
-13.33×
Q4 25
13.93×
Q3 25
2.54×
7.58×
Q2 25
5.58×
2.97×
Q1 25
1.90×
-5.70×
Q4 24
8.74×
17.00×
Q3 24
7.99×
9.38×
Q2 24
7.35×
9.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PCH
PCH

Lumber$131.8M42%
Timberlands$52.5M17%
Rural Real Estate$51.3M16%
Residuals And Panels$34.0M11%
Pulpwood$16.7M5%
Development Real Estate$14.6M5%
Other$8.1M3%
Other Products$5.2M2%

PRVA
PRVA

FFS-patient care$391.1M65%
Capitated revenue$86.1M14%
Other$75.0M12%
FFS-administrative services$31.4M5%
Care management fees (PMPM)$17.9M3%
Other revenue$2.3M0%

Related Comparisons